Excerpt:
Health care industry supplier Cardinal Health Inc. and certain of its investors got final approval Wednesday for their $109 million deal to end claims that Cardinal acquired a Johnson & Johnson unit without disclosing inventory and supply chain issues its acquisition target faced. [...]